a public good project by the
Synthesis
Company
of California

© 2026

Ying Wan | doi.page

0 works0 citations0 h-index

Ying Wan

Gilead Sciences (United States)(US)Nanxi Mountain Hospital(CN)

Publications by Year

Research Areas

Parkinson's Disease Mechanisms and Treatments, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, MicroRNA in disease regulation, interferon and immune responses

Most-Cited Works

→ Cancer-cell-derived GABA promotes β-catenin-mediated tumour growth and immunosuppression(2022)304 cited
→ Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation(2011)299 cited
→ Altered microRNA expression profile with miR-146a upregulation in CD4+T cells from patients with rheumatoid arthritis(2010)251 cited
→ miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110(2014)215 cited
→ Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo‐controlled study(2004)177 cited
→ Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression(2014)124 cited

→ A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy(2006)

93 cited

→ Malnutrition and associated factors in Chinese patients with Parkinson's disease: Results from a pilot investigation(2009)90 cited

→ A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis(2013)81 cited

→ Fermentation supernatants of Lactobacillus delbrueckii inhibit growth of human colon cancer cells and induce apoptosis through a caspase 3-dependent pathway(2014)73 cited